5781 - 5790 of 9148 Results
Title
Year
-
OPENTitle: Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 119Issue #:Start Page: 105954End Page: 105954Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105954Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10903276/pdf/nihms-1966735.pdfCitation Count: 3
- Loss of parkin causes endoplasmic reticulum calcium dyshomeostasis by upregulation of reticulocalbin 12023OPENTitle: Loss of parkin causes endoplasmic reticulum calcium dyshomeostasis by upregulation of reticulocalbin 1Journal Name: European Journal of NeurosciencePublisher: WileyVol: 57Issue #: 5Start Page: 739End Page: 761Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ejn.15917Citation Count: 6
-
OPENTitle: Neurophysics Assessment of the Muscle Bioenergy Generated by Transcranial Magnetic StimulationJournal Name: ResearchPublisher: American Association for the Advancement of Science (AAAS)Vol: 2019Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2019/7109535Best OA location URL: https://doi.org/10.1155/2019/7109535Citation Count: 2
- Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease Severity2016OPENTitle: Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease SeverityJournal Name: Oxidative Medicine and Cellular LongevityPublisher: WileyVol: 2016Issue #: 1Start Page: 9409363End Page: 9409363Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/9409363Best OA location URL: http://downloads.hindawi.com/journals/omcl/2016/9409363.pdfCitation Count: 93
-
OPENTitle: Sacral nerve stimulation improves gait in Parkinson's diseaseJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 4Start Page: 1075End Page: 1076Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.03.074Best OA location URL: https://doaj.org/article/1a3d778a5f164f45882a79a2adfcbf97Citation Count: 0
- Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset2022RESTRICTEDTitle: Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmosetJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 939Issue #:Start Page: 175429End Page: 175429Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2022.175429Citation Count: 6
-
OPENTitle: Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisitedJournal Name: Human Brain MappingPublisher: WileyVol: 37Issue #: 7Start Page: 2547End Page: 2556Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23192Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23192Citation Count: 81
-
OPENTitle: Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degenerationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 49End Page: 59Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.196Best OA location URL: https://doi.org/10.1016/j.jalz.2019.08.196Citation Count: 46
-
OPENTitle: The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stressJournal Name: Redox BiologyPublisher: Elsevier BVVol: 19Issue #:Start Page: 62End Page: 73Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.redox.2018.07.021Best OA location URL: https://doi.org/10.1016/j.redox.2018.07.021Citation Count: 93
- Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?2022RESTRICTEDTitle: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1346End Page: 1359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29058Citation Count: 20